Kronos Bio

About:

Kronos Bio focuses on the research and development of first-in-class therapies that modulate historically recalcitrant cancer.

Website: http://www.kronosbio.com

Twitter/X: kronosbio

Top Investors: BlackRock, Google Ventures, Fidelity, Perceptive Advisors, Invus

Description:

Kronos Bio focuses on the research and development of first-in-class therapies that modulate historically recalcitrant cancer targets. It develops therapies that modulate historically undruggable targets. The company leverages deep capabilities in high-throughput small-molecule microarrays (SMM), targeted protein degradation, and cancer biology in order to identify potent and selective compounds against transcription factors and other central drivers of oncogenic signaling.